Literature DB >> 16973366

Facile synthesis of non-steroidal anti-inflammatory active bisbenzamide-containing compounds.

Adel S Girgis1, Mohey Ellithey.   

Abstract

A variety of N,N'-bis{2-[1,2-ethanediylbis(oxy-2,1-phenylene)]-1-(substituted carbonyl)ethenyl}benzamides 7a-c, 9a-d were synthesized via nucleophilic attack of either primary 8 or secondary amines 6 on bisoxazol-5(4H)-one 5. The latter was obtained through the reaction of 2,2'-[1,2-ethanediylbis(oxy)]bisbenzaldehyde (4) with hippuric acid in acetic anhydride in the presence of anhydrous sodium acetate. The anti-inflammatory properties of the prepared compounds were screened using carrageenan-induced paw oedema in rats. Many of the prepared bisbenzamide-containing compounds show considerable in vivo anti-inflammatory activity, especially 7b which reveals remarkable pharmacological properties comparable with ketoprofen (which was used as a reference standard) at successive time intervals (1, 2, 3, 4 and 24h).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973366     DOI: 10.1016/j.bmc.2006.08.032

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  An efficient and facile synthesis of 3-amino-5-chromenyl-butenolides from 3-formyl chromone, dialkyl acetylenedicarboxylate, and primary amines.

Authors:  Saeed Balalaie; Morteza Ashouriha; Frank Rominger; Hamid Reza Bijanzadeh
Journal:  Mol Divers       Date:  2013-01-23       Impact factor: 2.943

2.  5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules.

Authors:  Evangelos Mavridis; Eleftherios Bermperoglou; Eleni Pontiki; Dimitra Hadjipavlou-Litina
Journal:  Molecules       Date:  2020-07-11       Impact factor: 4.411

3.  Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues.

Authors:  Md Jahangir Alam; Ozair Alam; Suroor Ahmad Khan; Mohd Javed Naim; Mohammad Islamuddin; Girdhar Singh Deora
Journal:  Drug Des Devel Ther       Date:  2016-10-31       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.